The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Estimated costs of grade 3–4 all-cause and treatment-related adverse events for stage IV or recurrent non-small cell lung cancer (NSCLC) in the CheckMate 227 (CM-227) trial.
 
David D. Stenehjem
Consulting or Advisory Role - Beta Cat Pharmaceuticals; Bristol-Myers Squibb; Dracen; Salarius Pharmaceuticals
Research Funding - AstraZeneca; Bioverativ; Bristol-Myers Squibb; Novartis
 
Irene Santi
No Relationships to Disclose
 
Komal Gupte-Singh
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
John R. Penrod
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Meena Venkatachalam
Employment - PAREXEL
Consulting or Advisory Role - PAREXEL